Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abiomed, Inc.
Abiomed Announces Impella 2.5 Capacity Expansion Plans in Ireland
August 22nd, 2008
Abiomed, Inc. (NASDAQ: ABMD) announced that it had recently signed a long-term operating lease for a manufacturing facility in Athlone, Ireland. Abiomed expects to begin facility preparations immediately and currently anticipates that the first Impella 2.5 Cardiac Assist Device production line will be operational in approximately eighteen months. Abiomed's Impella 2.5 capacity expansion plans in Ireland are intended to meet anticipated long-term demand for the device and augment capacity from the Company's Aachen, Germany facility. In June 2008, Abiomed announced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Impella 2.5 that...
Source: Health Business Week (2008-08-22)
|
